|
SART3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.436000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.508800E-01 |
| Normal-vs-Stage2 |
9.890400E-01 |
| Normal-vs-Stage3 |
5.388400E-01 |
| Normal-vs-Stage4 |
9.578400E-01 |
| Stage1-vs-Stage2 |
2.788000E-01 |
| Stage1-vs-Stage3 |
2.813900E-02 |
| Stage1-vs-Stage4 |
2.223000E-01 |
| Stage2-vs-Stage3 |
6.191600E-01 |
| Stage2-vs-Stage4 |
9.758200E-01 |
| Stage3-vs-Stage4 |
5.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.852600E-01 |
| Normal-vs-AfricanAmerican |
5.122800E-01 |
| Normal-vs-Asian |
2.016800E-01 |
| Caucasian-vs-AfricanAmerican |
6.037800E-01 |
| Caucasian-vs-Asian |
6.125900E-02 |
| AfricanAmerican-vs-Asian |
1.792420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.869400E-01 |
| Normal-vs-Female |
1.392570E-01 |
| Male-vs-Female |
6.105900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.311000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.982600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.373800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.633400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.744800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.757600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.638200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.902600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.284820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.868820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.563680E-03 |
| Normal-vs-Grade 2 |
1.176170E-01 |
| Normal-vs-Grade 3 |
6.080000E-01 |
| Normal-vs-Grade 4 |
7.441400E-01 |
| Grade 1-vs-Grade 2 |
3.576000E-02 |
| Grade 1-vs-Grade 3 |
2.462700E-03 |
| Grade 1-vs-Grade 4 |
1.276390E-02 |
| Grade 2-vs-Grade 3 |
1.171640E-02 |
| Grade 2-vs-Grade 4 |
9.008500E-02 |
| Grade 3-vs-Grade 4 |
9.596400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.695800E-02 |
| Normal-vs-ccB subtype |
5.253400E-01 |
| ccA subtype-vs-ccB subtype |
2.775800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.088000E-01 |
| Normal-vs-N1 |
5.635800E-01 |
| N0-vs-N1 |
5.516400E-01 |
|
|
